Side effects across medicines
Medicines whose labels list neuropathy peripheral
203 medicines have an FDA label that names neuropathy peripheral in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of neuropathy peripheral name lenalidomide (12,164), bortezomib (6,475) and paclitaxel (3,933), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list neuropathy peripheral?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 150 of the 203 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of neuropathy peripheral |
|---|---|---|
| Ciprofloxacin | boxed warning (intravenous label) | 3,117 |
| Levofloxacin | boxed warning (intravenous label) | 1,208 |
| Moxifloxacin | boxed warning (intravenous label) | 672 |
| Ofloxacin | boxed warning (oral label) | 100 |
| Paclitaxel | precautions | 3,933 |
| Cisplatin | precautions | 1,228 |
| Linezolid | warnings and precautions (oral label) | 989 |
| Metronidazole | warnings and precautions (vaginal label) | 899 |
| Fludarabine | precautions | 269 |
| Posaconazole | warnings and precautions (intravenous label) | 123 |
| Dapsone | warnings and precautions (topical label) | 122 |
| Mosunetuzumab | warnings and precautions (intravenous label) | none in the top 1,000 |
| Onasemnogene abeparvovec | warnings and precautions (intrathecal label) | none in the top 1,000 |
| Sulindac | precautions | none in the top 1,000 |
| Lenalidomide | adverse reactions | 12,164 |
| Bortezomib | adverse reactions | 6,475 |
| Cyclophosphamide | adverse reactions | 3,476 |
| Capecitabine | adverse reactions | 2,897 |
| Pomalidomide | adverse reactions | 2,669 |
| Atorvastatin | adverse reactions | 2,430 |
| Pembrolizumab | adverse reactions | 2,052 |
| Thalidomide | adverse reactions | 1,823 |
| Simvastatin | adverse reactions | 1,747 |
| Amlodipine | adverse reactions | 1,735 |
| Insulin lispro | adverse reactions | 1,491 |
| Ixazomib | adverse reactions | 1,451 |
| Palbociclib | adverse reactions | 1,389 |
| Allopurinol | adverse reactions | 1,274 |
| Pertuzumab | adverse reactions | 1,123 |
| Enfortumab vedotin | adverse reactions | 852 |
| Insulin aspart | adverse reactions (intravenous/ | 756 |
| Leflunomide | adverse reactions | 749 |
| Brentuximab vedotin | adverse reactions | 711 |
| Carfilzomib | adverse reactions | 693 |
| Nivolumab | adverse reactions | 693 |
| Insulin human | adverse reactions | 664 |
| Fulvestrant | adverse reactions | 621 |
| Rosuvastatin | adverse reactions | 619 |
| Ibrutinib | adverse reactions | 588 |
| Sulfasalazine | adverse reactions | 520 |
| Cetuximab | adverse reactions | 496 |
| Teriflunomide | adverse reactions | 492 |
| Atezolizumab | adverse reactions | 464 |
| Trastuzumab emtansine | adverse reactions | 454 |
| Cyclobenzaprine | adverse reactions | 448 |
| Aprepitant | adverse reactions | 437 |
| Polatuzumab vedotin | adverse reactions | 346 |
| Ifosfamide | adverse reactions | 281 |
| Enalapril | adverse reactions | 250 |
| Ritonavir | adverse reactions | 241 |
| Leuprolide | adverse reactions | 237 |
| Lovastatin | adverse reactions | 235 |
| Rucaparib camsylate | adverse reactions | 235 |
| Isoniazid | adverse reactions | 227 |
| Vinorelbine | adverse reactions | 221 |
| Eribulin | adverse reactions | 214 |
| Nitrofurantoin | adverse reactions | 213 |
| Tucatinib | adverse reactions | 208 |
| Durvalumab | adverse reactions | 196 |
| Lorlatinib | adverse reactions | 195 |
| Fosaprepitant | adverse reactions | 190 |
| Carbidopa and levodopa | adverse reactions | 185 |
| Ribavirin | adverse reactions | 180 |
| Itraconazole | adverse reactions | 173 |
| Mesalamine | adverse reactions | 171 |
| Peginterferon alfa 2a | adverse reactions | 166 |
| Nilotinib | adverse reactions | 154 |
| Tenofovir disoproxil | adverse reactions | 149 |
| Gentamicin | adverse reactions (intramuscular/ | 144 |
| Selinexor | adverse reactions | 139 |
| Trametinib | adverse reactions | 132 |
| Amitriptyline | adverse reactions | 131 |
| Nortriptyline | adverse reactions | 122 |
| Ezetimibe and simvastatin | adverse reactions | 120 |
| Dabrafenib | adverse reactions | 115 |
| Elotuzumab | adverse reactions | 114 |
| Mirvetuximab soravtansine | adverse reactions | 114 |
| Encorafenib | adverse reactions | 111 |
| Lopinavir and ritonavir | adverse reactions | 104 |
| Trastuzumab deruxtecan | adverse reactions | 103 |
| Daratumumab and hyaluronidase | adverse reactions | 99 |
| Hydrochlorothiazide and lisinopril | adverse reactions | 95 |
| Insulin glulisine | adverse reactions | 86 |
| Indomethacin | adverse reactions | 83 |
| Pitavastatin | adverse reactions | 82 |
| Crizotinib | adverse reactions | 81 |
| Pretomanid | adverse reactions | 78 |
| Valganciclovir | adverse reactions | 76 |
| Isatuximab | adverse reactions (subcutaneous label) | 74 |
| Tisotumab vedotin | adverse reactions | 74 |
| Amiodarone | adverse reactions | 68 |
| Dostarlimab | adverse reactions | 66 |
| Vemurafenib | adverse reactions | 65 |
| Lamivudine and zidovudine | adverse reactions | 62 |
| Etravirine | adverse reactions | 61 |
| Binimetinib | adverse reactions | 60 |
| Cabazitaxel | adverse reactions | 60 |
| Nelarabine | adverse reactions | 60 |
| Ranibizumab | adverse reactions | 60 |
| Ponatinib | adverse reactions | 55 |
| Momelotinib | adverse reactions | 54 |
| Ixabepilone | adverse reactions | 52 |
| Teclistamab | adverse reactions | 45 |
| Abacavir and dolutegravir and lamivudine | adverse reactions | none in the top 1,000 |
| Abacavir and lamivudine | adverse reactions | none in the top 1,000 |
| Abacavir and lamivudine and zidovudine | adverse reactions | none in the top 1,000 |
| Acitretin | adverse reactions | none in the top 1,000 |
| Adagrasib | adverse reactions | none in the top 1,000 |
| Aldesleukin | adverse reactions | none in the top 1,000 |
| Amitriptyline and perphenazine | adverse reactions | none in the top 1,000 |
| Amivantamab and hyaluronidase | adverse reactions | none in the top 1,000 |
| Amlodipine and atorvastatin | adverse reactions | none in the top 1,000 |
| Amlodipine and benazepril | adverse reactions | none in the top 1,000 |
| Amlodipine and telmisartan | adverse reactions | none in the top 1,000 |
| Arsenic trioxide | adverse reactions | none in the top 1,000 |
| Asciminib | adverse reactions | none in the top 1,000 |
| Asparaginase | adverse reactions | none in the top 1,000 |
| Atezolizumab and hyaluronidase | adverse reactions | none in the top 1,000 |
| Auranofin | adverse reactions | none in the top 1,000 |
| Avutometinib and defactinib | adverse reactions | none in the top 1,000 |
| Belzutifan | adverse reactions | none in the top 1,000 |
| Benznidazole | adverse reactions | none in the top 1,000 |
| Berahyaluronidase alfa and pembrolizumab | adverse reactions | none in the top 1,000 |
| Bexagliflozin | adverse reactions | none in the top 1,000 |
| Bismuth subcitrate and metronidazole and tetracycline | adverse reactions | none in the top 1,000 |
| Brigatinib | adverse reactions | none in the top 1,000 |
| Cedazuridine and decitabine | adverse reactions | none in the top 1,000 |
| Cemiplimab | adverse reactions | none in the top 1,000 |
| Ceritinib | adverse reactions | none in the top 1,000 |
| Chlorambucil | adverse reactions | none in the top 1,000 |
| Cholic acid | adverse reactions | none in the top 1,000 |
| Cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil | adverse reactions | none in the top 1,000 |
| Dactinomycin | adverse reactions | none in the top 1,000 |
| Daptomycin | adverse reactions | none in the top 1,000 |
| Daraxonrasib | adverse reactions | none in the top 1,000 |
| Dasatinib | adverse reactions | none in the top 1,000 |
| Delafloxacin | adverse reactions | none in the top 1,000 |
| Denileukin diftitox | adverse reactions | none in the top 1,000 |
| Desipramine | adverse reactions | none in the top 1,000 |
| Dinutuximab | adverse reactions | none in the top 1,000 |
| Disulfiram | adverse reactions | none in the top 1,000 |
| Dolutegravir and lamivudine | adverse reactions | none in the top 1,000 |
| Dordaviprone | adverse reactions | none in the top 1,000 |
| Efavirenz and lamivudine and tenofovir disoproxil | adverse reactions | none in the top 1,000 |
| Elranatamab | adverse reactions | none in the top 1,000 |
| Emtricitabine and rilpivirine and tenofovir disoproxil | adverse reactions | none in the top 1,000 |
| Enalapril and hydrochlorothiazide | adverse reactions | none in the top 1,000 |
| Enalaprilat | adverse reactions | none in the top 1,000 |
| Entrectinib | adverse reactions | none in the top 1,000 |
| Epcoritamab | adverse reactions | none in the top 1,000 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most neuropathy peripheral reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Neuropathy Peripheral”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch